BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
H. Ishigami, J. Kitayama, S. Kaisaki, A. Hidemura, M. Kato, K. Otani, T. Kamei, D. Soma, H. Miyato, H. Yamashita, H. Nagawa. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasisAnnals of Oncology 2010; 21(1): 67 doi: 10.1093/annonc/mdp260
2
Satoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada. Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective studyInternational Journal of Clinical Oncology 2011; 16(1): 57 doi: 10.1007/s10147-010-0135-9
3
Hiromichi Maeda, Michiya Kobayashi, Junichi Sakamoto. Evaluation and treatment of malignant ascites secondary to gastric cancerWorld Journal of Gastroenterology 2015; 21(39): 10936-10947 doi: 10.3748/wjg.v21.i39.10936
4
Naminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, Hironori Ishigami, Sohei Satoi, Suguru Mizuno, Hirofumi Kogure, Saburo Matsubara, Natsuyo Yamamoto, Hironori Yamaguchi, Minoru Tada, Joji Kitayama, Toshiaki Watanabe, Kazuhiko Koike. Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascitesInvestigational New Drugs 2016; 34(5): 636 doi: 10.1007/s10637-016-0369-0
5
Yasuo Hamamoto, Yongzhe Piao, Akitaka Makiyama. Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascitesGastric Cancer 2020; 23(3): 363 doi: 10.1007/s10120-020-01067-3
6
Rai Shimoyama, Hirofumi Yasui, Narikazu Boku, Yusuke Onozawa, Shuichi Hironaka, Akira Fukutomi, Kentaro Yamazaki, Keisei Taku, Takashi Kojima, Nozomu Machida, Akiko Todaka, Hideharu Tomita, Takeshi Sakamoto, Takahiro Tsushima. Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatinGastric Cancer 2009; 12(4): 206 doi: 10.1007/s10120-009-0524-9
7
Motohiro Imano, Atsushi Yasuda, Tatsuki Itoh, Takao Satou, Ying-Feng Peng, Hiroaki Kato, Masayuki Shinkai, Masahiro Tsubaki, Yasutaka Chiba, Takushi Yasuda, Haruhiko Imamoto, Shozo Nishida, Yoshifumi Takeyama, Kiyokata Okuno, Hiroshi Furukawa, Hitoshi Shiozaki. Phase II Study of Single Intraperitoneal Chemotherapy Followed by Systemic Chemotherapy for Gastric Cancer with Peritoneal MetastasisJournal of Gastrointestinal Surgery 2012; 16(12): 2190 doi: 10.1007/s11605-012-2059-3
8
Naoto Takahashi, Mitsuro Kanda, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Katsufumi Miyamoto, Yuichi Ito, Osamu Takayama, Motohiro Imano, Norio Mitsumori, Junichi Sakamoto, Satoshi Morita, Yasuhiro Kodera. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trialGastric Cancer 2018; 21(6): 1014 doi: 10.1007/s10120-018-0817-y
9
Yasushi Sekino, Yasuhiro Koyano, Yusuke Shimodaira, Yusuke Takahashi, Masao Okada, Kaori Hayashibara, Masahiro Sakon, Manabu Takata, Hitoshi Seki, Yasuhiro Munakata. Long-Term Survival for 8 Years of Peritoneal Recurrence of a Gastric Cancer Treated with S-1/docetaxel Combination ChemotherapyThe Japanese Journal of Gastroenterological Surgery 2018; 51(9): 566 doi: 10.5833/jjgs.2017.0158
10
Brinda Rao Korivi, Silvana Faria, Asran Aly, Jia Sun, Madhavi Patnana, Corey T. Jensen, Nicolaus Wagner-Bartak, Priya R. Bhosale. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sitesClinical Imaging 2019; 56: 33 doi: 10.1016/j.clinimag.2019.03.002
11
JUNLI MA, HONG SHEN, LINDA KAPESA, SHAN ZENG. Lauren classification and individualized chemotherapy in gastric cancerOncology Letters 2016; 11(5): 2959 doi: 10.3892/ol.2016.4337
12
Junichi Sakamoto, Takanori Matsui, Yasuhiro Kodera. Paclitaxel chemotherapy for the treatment of gastric cancerGastric Cancer 2009; 12(2): 69 doi: 10.1007/s10120-009-0505-z
13
Yasuhiro Kodera, Naoto Takahashi, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Yuichi Ito, Katsufumi Miyamoto, Osamu Takayama, Motohiro Imano, Daisuke Kobayashi, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto. Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trialGastric Cancer 2017; 20(1): 190 doi: 10.1007/s10120-016-0598-0
14
Akira Tsuburaya, Naoki Nagata, Haruhiko Cho, Naoki Hirabayashi, Michiya Kobayashi, Hiroshi Kojima, Yasuhiro Munakata, Ryoji Fukushima, Yoichi Kameda, Tadakazu Shimoda, Koji Oba, Junichi Sakamoto. Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancerCancer Chemotherapy and Pharmacology 2013; 71(5): 1309 doi: 10.1007/s00280-013-2130-0
15
Michiya Kobayashi, Akira Tsuburaya, Naoki Nagata, Yumi Miyashita, Koji Oba, Junichi Sakamoto. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancerGastric Cancer 2006; 9(2): 114 doi: 10.1007/s10120-006-0364-9
16
Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kozo Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Toshihiro Nakao. Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer: phase I studyThe Journal of Medical Investigation 2011; 58(1,2): 134 doi: 10.2152/jmi.58.134
17
Simon J. Hogg, John J. Evans, Peter H. Sykes, Kenny Chitcholtan. A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput formatJournal of Ovarian Research 2015; 8(1) doi: 10.1186/s13048-015-0172-0
18
Hiroki Hara, Shigenori Kadowaki, Masako Asayama, Akira Ooki, Toko Yamada, Takako Yoshii, Kensei Yamaguchi. First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intakeInternational Journal of Clinical Oncology 2018; 23(2): 275 doi: 10.1007/s10147-017-1198-7
19
Naminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, Takashi Sasaki, Hironori Ishigami, Hiroharu Yamashita, Hironori Yamaguchi, Tsuyoshi Hamada, Rie Uchino, Suguru Mizuno, Koji Miyabayashi, Dai Mohri, Kazumichi Kawakubo, Hirofumi Kogure, Natsuyo Yamamoto, Naoki Sasahira, Kenji Hirano, Hideaki Ijichi, Keisuke Tateishi, Minoru Tada, Joji Kitayama, Toshiaki Watanabe, Kazuhiko Koike. Intravenous and Intraperitoneal Paclitaxel with S-1 for Refractory Pancreatic Cancer with Malignant Ascites: an Interim AnalysisJournal of Gastrointestinal Cancer 2014; 45(3): 307 doi: 10.1007/s12029-014-9603-1
20
B. Frazier Taylor, Samuel C. McNeely, Heather L. Miller, J. Christopher States. Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerizationToxicology and Applied Pharmacology 2008; 230(2): 235 doi: 10.1016/j.taap.2008.02.030
21
Ying-Feng Peng, Motohiro Imano, Tatsuki Itoh, Takao Satoh, Yasutaka Chiba, Haruhiko Imamoto, Masahiro Tsubaki, Shozo Nishida, Takushi Yasuda, Hiroshi Furukawa. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancerJournal of Surgical Oncology 2015; 111(8): 1041 doi: 10.1002/jso.23928
22
Yasuomi Shimizu, Satoshi Tamada, Minoru Kato, Yukiyoshi Hirayama, Yuji Takeyama, Taro Iguchi, Marianne Sadar, Tatsuya Nakatani. Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane ChemotherapyJournal of Clinical Medicine 2018; 7(11): 444 doi: 10.3390/jcm7110444
23
Yasunori Emi, Manabu Yamamoto, Ikuo Takahashi, Hiroyuki Orita, Yoshihiro Kakeji, Shunji Kohnoe, Yoshihiko Maehara. Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancerSurgery Today 2008; 38(11): 1013 doi: 10.1007/s00595-008-3769-8
24
Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, Ichinosuke Hyodo, Junki Mizusawa, Hiroki Hara, Tomohiro Nishina, Takeshi Sakamoto, Kohei Shitara, Katsunori Shinozaki, Hiroshi Katayama, Shinichiro Nakamura, Kei Muro, Masanori Terashima. Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)Gastric Cancer 2020; 23(4): 677 doi: 10.1007/s10120-020-01043-x
25
Nan Liu, Yijie Zheng, Ying Zhu, Shudao Xiong, Yiwei Chu. Selective Impairment of CD4+CD25+Foxp3+Regulatory T cells by paclitaxel is explained by Bcl-2/Bax mediated apoptosisInternational Immunopharmacology 2011; 11(2): 212 doi: 10.1016/j.intimp.2010.11.021
26
Akira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi, Shigefumi Yoshino, Masazumi Takahashi, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoto Takahashi, Hiroshi Imamura, Naokuni Tatsumoto, Akinori Hara, Kazuhiro Nishikawa, Ryoji Fukushima, Isao Nozaki, Hiroshi Kojima, Yumi Miyashita, Koji Oba, Marc Buyse, Satoshi Morita, Junichi Sakamoto. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trialThe Lancet Oncology 2014; 15(8): 886 doi: 10.1016/S1470-2045(14)70025-7
27
Shigeyuki Tamura, Hirofumi Miki, Kaoru Okada, Atsushi Takeno, Kumiko Uji, Atsuko Yoshida, Rei Suzuki, Shin Nakahira, Chiyomi Egawa, Ken Nakata, Shu Okamura, Keishi Sugimoto, Yuichi Takatsuka. Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancerGastric Cancer 2010; 13(2): 101 doi: 10.1007/s10120-010-0547-2
28
Yoshinao Ohbatake, Sachio Fushida, Tomoya Tsukada, Jun Kinoshita, Katsunobu Oyama, Hironori Hayashi, Tomoharu Miyashita, Hidehiro Tajima, Hiroyuki Takamura, Itasu Ninomiya, Masakazu Yashiro, Kousei Hirakawa, Tetsuo Ohta. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycinClinical and Experimental Medicine 2016; 16(4): 585 doi: 10.1007/s10238-015-0387-9
29
Masayuki Kano, Koichi Hayano, Hideki Hayashi, Naoyuki Hanari, Hisashi Gunji, Takeshi Toyozumi, Kentaro Murakami, Masaya Uesato, Satoshi Ota, Hisahiro Matsubara. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched AnalysisAnnals of Surgical Oncology 2019; 26(6): 1805 doi: 10.1245/s10434-019-07299-7
30
Kunitoshi Shigeyasu, Shunsuke Kagawa, Futoshi Uno, Masahiko Nishizaki, Hiroyuki Kishimoto, Akira Gochi, Toshikazu Kimura, Takaomi Takahata, Yasuyuki Nonaka, Motoki Ninomiya, Toshiyoshi Fujiwara. Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal disseminationCancer Chemotherapy and Pharmacology 2013; 71(4): 937 doi: 10.1007/s00280-013-2086-0
31
Koji Kono, Wei-Peng Yong, Hirokazu Okayama, Asim Shabbir, Tomoyuki Momma, Shinji Ohki, Seiichi Takenoshita, Jimmy So. Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and JapanGastric Cancer 2017; 20(S1): 122 doi: 10.1007/s10120-016-0660-y
32
Hiroshi Ono, Ryo Mafune, Taiyu Hayashi, Yasushi Misaki, Yukihiro Kaneko, Jumpei Saito, Miki Nagai, Hitoshi Kato. Paclitaxel-coated drug-eluting balloon for pulmonary vein stenosis after repair of total anomalous pulmonary venous return with aspleniaJournal of Cardiology Cases 2020; 22(3): 107 doi: 10.1016/j.jccase.2020.05.008
33
Thanigaivel Shanmugam, Nitin Joshi, Nadim Ahamad, Atul Deshmukh, Rinti Banerjee. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancerInternational Journal of Pharmaceutics 2020; 586: 119482 doi: 10.1016/j.ijpharm.2020.119482
34
Haruhiko Imamoto, Koji Oba, Junichi Sakamoto, Hiroyasu Iishi, Hiroyuki Narahara, Takeyoshi Yumiba, Takashi Morimoto, Masaki Nakamura, Noboru Oriuchi, Chieko Kakutani, Satoshi Morita, Hitoshi Shiozaki. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancerGastric Cancer 2011; 14(1): 81 doi: 10.1007/s10120-011-0016-6
35
Masayuki Shinkai, Motohiro Imano, Yasutaka Chiba, Mitsuru Iwama, Osamu Shiraisi, Atsushi Yasuda, Masanobu Tsubaki, Shozo Nishida, Yutaka Kimura, Takushi Yasuda. Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S‐1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancerJournal of Surgical Oncology 2019; 119(1): 56 doi: 10.1002/jso.25295
36
Md Abul Barkat, Sarwar Beg, Faheem H Pottoo, Farhan J Ahmad. Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challengesNanomedicine 2019; 14(10): 1323 doi: 10.2217/nnm-2018-0313
37
Joji Kitayama, Hironori Ishigami, Hironori Yamaguchi, Yasunaru Sakuma, Hisanaga Horie, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata. Treatment of patients with peritoneal metastases from gastric cancerAnnals of Gastroenterological Surgery 2018; 2(2): 116 doi: 10.1002/ags3.12060
38
Xin Zhang, Hejing Huang, Ziran Wei, Zhenxin Zhu, Dejun Yang, Hongbing Fu, Jiapeng Xu, Zunqi Hu, Yu Zhang, Qing You, Xin Huang, Ronglin Yan, Weimin Wang, Qingping Cai. <p>Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis</p>Cancer Management and Research 2020; : 6641 doi: 10.2147/CMAR.S258360
39
Motohiro Imano, Kiyotaka Okuno. Treatment strategies for gastric cancer patients with peritoneal metastasisSurgery Today 2014; 44(3): 399 doi: 10.1007/s00595-013-0603-8
40
Satoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada. First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancerGastric Cancer 2012; 15(1): 21 doi: 10.1007/s10120-011-0056-y
41
Takahisa Yamaguchi, Sachio Fushida, Yasuhiko Yamamoto, Tomoya Tsukada, Jun Kinoshita, Katsunobu Oyama, Tomoharu Miyashita, Hidehiro Tajima, Itasu Ninomiya, Seiichi Munesue, Ai Harashima, Shinichi Harada, Hiroshi Yamamoto, Tetsuo Ohta. Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancerOncology Reports 2017; 37(6): 3341 doi: 10.3892/or.2017.5586